New efficacy data from Brazil on Sinovac's Covid-19 vaccine, for which there are now four widely different success rates, raised more questions than answers, as many developing countries pin their hopes on the CoronaVac to end the pandemic.
Here are potential factors contributing to CoronaVac's varying efficacy rates and expert interpretations...
All Access Plan
starting from
~RM12
per month
You can cancel anytime.
Get unlimited access to our articles on web and apps
Add comments to our articles
Bookmark articles to read later
We accept
Already Subscribed?